[Therapy of hyperammonemia: effect of a preparation arginine pyrrolidonecarboxylate, taurine, vitamin B6 and citric acid].
D000596:Amino Acids / Q000627:therapeutic use*; D000641:Ammonia / Q000097:blood*; D001120:Arginine / Q000627:therapeutic use*; D001927:Brain Diseases / Q000209:etiology; D002951:Citrates / Q000627:therapeutic use*; D004338:Drug Combinations; D006501:Hepatic Encephalopathy / Q000209:etiology; D006801:Humans; D008107:Liver Diseases / Q000150:complications* / Q000188:drug therapy; D011736:Pyridoxine / Q000627:therapeutic use*; D011760:Pyrrolidinones / Q000627:therapeutic use*; D011761:Pyrrolidonecarboxylic Acid / Q000627:therapeutic use; D013654:Taurine / Q000627:therapeutic use*
D000596:Amino Acids; D002951:Citrates; D004338:Drug Combinations; D011760:Pyrrolidinones; D013654:Taurine; D000641:Ammonia; D001120:Arginine; D011736:Pyridoxine; D011761:Pyrrolidonecarboxylic Acid
Terapia dell'iperammoniemia: azione di un farmaco a base di pirrolidoncarbossilato di arginina, taurina, vitamina B 6  ed acido citrico.